Trial Profile
A Real‐Life Study Assessing the Effectiveness and Safety of Sofosbuvir (SOF)/Simeprevir (SMV) with or without Ribavirin (RBV) in a Large Cohort of Spanish Cirrhotic Patients Infected with Hepatitis C Genotypes 1 and 4
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2018
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 31 Jul 2018 New trial record